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Summary
A complex relationship between the microbiota and the host emerges
early at birth and continues throughout life. The microbiota includes the
prokaryotes, viruses and eukaryotes living among us, all of which interact
to different extents with various organs and tissues in the body, including
the immune system. Although the microbiota is most dense in the lower
intestine, its influence on host immunity extends beyond the gastrointesti-
nal tract. These interactions with the immune system operate through the
actions of various microbial structures and metabolites, with outcomes
ranging from beneficial to deleterious for the host. These differential out-
comes are dictated by host factors, environment, and the type of microbes
or products present in a specific ecosystem. It is also becoming clear that
the microbes are in turn affected and respond to the host immune sys-
tem. Disruption of this complex dialogue between host and microbiota
can lead to immune pathologies such as inflammatory bowel diseases, dia-
betes and obesity. This review will discuss recent advances regarding the
ways in which the host immune system and microbiota interact and com-
municate with one another.
Keywords: host–microbe interactions; immunology; microbiota.
Introduction
The microbiota refers to the population of microbes
(prokaryotes, viruses and eukaryotes) living among us,
outnumbering host cells by a factor of 10.1,2 The host
immune system encompasses both the innate and adap-
tive immune systems, which work together to determine
the class of microbial threat and direct the type and
degree of immune response to the exposure.3 The
immune system and microbiota develop and mature
together, beginning at birth, or even potentially in the
womb.4 This early coexistence is probably essential in
shaping the immune system response to avoid unwanted
immune reactions to intestinal microbial components. An
inappropriate response to indigenous bacteria could have
deleterious consequences for the host as seen with inflam-
matory bowel diseases (IBD).
The importance of the microbiota in shaping host
immunity is best appreciated in germ-free (GF) models.
Germ-free housing conditions maintain a microorganism-
free environment and are a powerful system within which
to dissect various aspects of host–microbe interactions.
Germ-free mice display an ‘underdeveloped’ innate and
adaptive immune system: reduced expression of antimicro-
bial peptides, reduced IgA production, fewer T-cell types
and increased susceptibility to microbial infections.5 The
deficits of GF mice highlight the key role of microbes in
bringing the immune system into a ‘combat ready’ mode.
Studies comparing monozygotic and dizygotic twins sug-
gest that non-heritable influences from the environment,
Abbreviations: AIEC, adherent invasive Escherichia coli; AhR, aryl hydrocarbon receptor; DC, dendritic cell; DSS, dextran
sulphate sodium; GF, germ-free; GPRs, G protein-coupled receptors; IBD, inflammatory bowel diseases; IECs, intestinal epithelial
cells; IELs, intraepithelial lymphocytes; IL-17, interleukin-17; ILCs, innate lymphoid cells; ILC3, group 3 innate lymphoid cell;
iNKT, invariant natural killer T cell; MHCII, major histocompatibility complex class II; MyD88, myeloid differentiation primary
response protein 88; NLRs, nod-like receptors; NLRP3, NLR family, pyrin domain containing 3; OMVs, outer membrane vesi-
cles; PRRs, pattern recognition receptors; PSA, polysaccharide A from Bacteroides fragilis; SCFAs, short chain fatty acids; SFB,
segmented filamentous bacteria; Th17, T helper 17 lymphocyte; TIGIT, T cell Immunoreceptor with Ig and ITIM domains;
TLRs, Toll-like receptors; TRAF6, tumour necrosis factor receptor associated factor 6; Treg, T regulatory lymphocyte; TRIF,
Toll–interleukin receptor domain-containing adaptor protein inducing interferon-b
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including the microbiota, determine much of the immune
variation seen in humans.6 Alterations in the microbiota,
referred to as dysbiosis, have been implicated as risk factors
for IBD, cancers, multiple sclerosis, asthma and type I dia-
betes; reinforcing the impact of the microbiota on host
health. Diet also has profound effects on microbiota com-
position and metabolite production, both of which influ-
ence host immunity but this element will not be discussed
here (for reviews, see refs 5,7). This review will focus on
recent advances in understanding how microbes and
microbial components interact with host immunity and
how these interactions influence host health.
Broad influence of microbiota on host immunity
Microbiota: intestinal effects
The establishment of a mature microbiota is a dynamic
process during the first 2 years of life5 and coincides with
the development of the immune system. Throughout the
early developmental period innate immune components
play key roles in protecting the infant from pathogens and
shaping microbiota assembly. IgA is found in breast milk
and can prevent immune activation in infants by binding
microbial antigens. Similarly, secretory IgA produced along
the intestinal tract continues to be important for maintain-
ing mucosal homeostasis through adulthood.8 The devel-
opment of the mature microbiota is regulated by host
immune system components, which can also be influenced
by members of the microbiota. Recent work with gnotobi-
otic mice suggests that proteobacteria, the dominant phy-
lum in newborns, triggers a proteobacteria-specific IgA
response in mice that plays a key role in controlling pro-
teobacteria levels in the adult microbiota.9 Faecal IgA levels
(low versus high) are partly controlled by members of the
microbiota; a phenotype that is vertically transmissible and
independent of host genetic factors.10 16S rRNA sequenc-
ing revealed that Sutterella species are partly responsible for
variable IgA levels, most probably by degrading IgA secre-
tory component10 (Fig. 1). Noteably, expansion of pro-
teobacteria/Enterobacteriaceae abundance is observed in
patients with IBD and in pre-clinical models.11 Whether
this bloom of microorganisms is related to microbe-
mediated faecal IgA levels is unknown.
The microbiota continues to affect immune function
well after development. Studies of Paneth cells using orga-
noids generated from mice reveal that degranulation (re-
lease of antimicrobial products) is controlled by immune-
cell-derived interferon-c, which may be induced in vivo
during viral or bacterial challenge.12 Thymic and induced T
regulatory (Treg) lymphocytes prevent autoimmunity and
maintain tolerance to the microbiota, and a recent study
suggests that most colonic Treg cells are thymic Treg cells
that recognize bacterial antigens, including antigens from
Clostridiales, Bacteroides and Lactobacillus. Importantly,
antibiotic-induced alterations in the microbiota, which
decrease Clostridiales members among others, reduce
intestinal Treg cells and alter colonic thymic Treg T-cell
receptor repertoire, suggesting that microbial composition
influences the dynamic response of Treg cells.13
One of the most studied immunomodulatory microbes
are segmented filamentous bacteria (SFB), which colonize
the terminal ileum in mice, induce IgA production and
increase effector T cells, particularly T helper type 17
(Th17) cells.1 Work from several groups suggests that
SFB induction of Th17 cells occurs in the intestinal lam-
ina propria rather than in Peyer’s patches or the mesen-
teric lymph nodes.14–16 Further studies revealed that
MHC class II (MHCII) -dependent antigen presentation
by intestinal dendritic cells (DCs) is essential for SFB-
induced Th17 cells.15,16 Additionally, Goto et al. provide
evidence that MHCII presentation by innate lymphoid
cells (ILCs) may constrain Th17 cell differentiation.15 The
SFB also stimulate expansion of germinal centres and
induce IgA-secreting cells in Peyer’s patches, isolated lym-
phoid follicles and tertiary lymphoid tissue.14 Recently,
Schnupf et al. cultured SFB in vitro and provided evi-
dence that SFB attachment in vivo is required to elicit
ileal epithelial responses.17 Future studies examining the
specific structural component(s) of SFB responsible for
stimulating IgA production and inducing Th17 cells could
be aided by the in vitro culture system. Although SFB
have not yet been isolated from the human gastrointesti-
nal tract, human cell lines support SFB growth17 and
SFB-specific 16S rRNA has been detected within human
stool samples.18 Gram-stained human ileal–caecal biopsies
from a small set of patients with IBD and non-inflamed
patients suggest that SFB is present in patients with ulcer-
ative colitis but absent in those with Crohn’s disease.19
Hence, future studies may reveal a role for SFB or SFB-
related bacteria in human immune development and IBD.
In addition to interactions with the immune system,
microbes interact with other microorganisms. Although
many symbionts have beneficial immune properties, some
bacteria facilitate host infection by viruses. For example,
human norovirus probably binds to histo-blood group
antigen-expressing bacteria such as Enterobacter cloacae,
which promotes attachment and infection of B cells.20
Conversely, treating mice with the bacterial product, flag-
ellin, prevents rotavirus infection by modulating host
innate immune signalling.21 Hence, microbiota composi-
tion can promote or inhibit viral infection depending on
the type of virus.
Microbiota effects on extra-intestinal immunity
The effects of the microbiota on host immunity extend
beyond the intestine. Germ-free zebrafish have fewer and
less active neutrophils compared with zebrafish colonized
with a normal microbiota, as well as impaired neutrophil
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recruitment in a tail-fin injury model; a phenomenon
linked to microbial induction of serum amyloid A.22
Neonatal mice that are GF or born from antibiotic-trea-
ted dams have fewer circulating and bone marrow neu-
trophils and are more susceptible to Escherichia coli K1
and Klebsiella pneumoniae sepsis, probably through
microbiota induction of granulocytosis.23 Hence, the
microbiota contributes to neutrophil development, home-
ostasis and function in both mice and zebrafish.22,23 The
GF mice have increased invariant natural killer T (iNKT)
cells in the lung and colon due to enhanced CXCL16
expression, making them more susceptible to an ovalbu-
min-driven model of allergic asthma.24 These studies also
suggest that early exposure to microbes is important, as
the iNKT cell levels returned to low levels when GF mice
were exposed to specific pathogen-free conditions upon
birth but not as adults.24 Consequently, the intestinal
microbiota has both local and systemic effects on innate
and adaptive immunity (Fig. 1).
Although the majority of the microbiota resides within
the intestine, the microbial communities located in extra-
intestinal regions also influence local host immunity.25
Studies comparing GF mice to conventionally raised mice
suggest that the skin microbiota regulates expression of
complement component C5a receptor, which regulates
innate immune defence genes, thereby impacting micro-
biota diversity and composition.26 Certain skin micro-
biota community members, particularly Staphylococcus
epidermidis interactions with CD103+ DCs, can induce
CD8+ T-cell migration to the epidermis, which enhances
barrier function and limits epicutaneous Candida albicans
infection through induction of interleukin-17 (IL-17).27
In a skin wound healing model, wound closure rate was
restored in GF mice conventionalized with microbiota, a
phenomenon associated with increased neutrophil accu-
mulation and lower macrophage infiltration into the
injured region.28 Microbial dysbiosis has also been impli-
cated in extraintestinal diseases, such as increased
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Figure 1. The microbiota affects local and systemic immunity. The intestine (1) contains the greatest number and diversity of microbiota mem-
bers. Proteobacteria, specifically Sutterella, alter faecal IgA levels, likely through degradation of SIgA. SFB also alter IgA levels by promoting the
expansion of germinal centres and inducing IgA-secreting cells in Peyer’s patches, isolated lymphoid follicles, and tertiary lymphoid tissue.
MHCII-dependent SFB antigen presentation on intestinal DCs induces Th17 cell differentiation, while MHCII-dependent SFB antigen presenta-
tion by ILCs constrains Th17 cell differentiation. The intestinal microbiota also influences systemic immunity, including the number and function
of circulating neutrophils (2) as well as constraining iNKT levels in the lung (3) and colon (1). DC, dendritic cell; ILCs, innate lymphoid cells;
iNKT, invariant natural killer T cell; SFB, segmented filamentous bacteria; SIgA, secretory immunoglobulin A; Th17, T helper 17 lymphocyte;
Treg, T regulatory lymphocyte.
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Staphylococcus aureus, which is associated with inflamma-
tory skin conditions.29 Hence, microbes occupying extra-
intestinal niches also influence host immunity, although
the specific organisms and mechanisms responsible for
these responses (Table 1) can differ between regions.
Bacterial components that effect innate and
adaptive immunity
Structures detected by pattern recognition receptors
The innate immune system detects microbial components
or products through several different families of pattern
recognition receptors (PRRs), found on numerous cell
types including macrophages, DCs and epithelial cells.3
Toll-like receptors (TLRs) are a class of transmembrane
PRRs located on either the cell surface or in endosomes.31
One of the most characterized bacterial immunomodula-
tors is Bacteroides fragilis polysaccharide A (PSA), which
is recognized by TLR2 and capable of influencing T-cell
development and homeostasis.32 Recent studies reveal that
PSA activates TLR2 on plasmacytoid DCs rather than
conventional DCs, leading to the induction of IL-10
secretion by CD4+ T cells and mucosal protection during
a 2,4,6-trinitrobenzene sulphonic acid model of colitis.33
PSA–TLR2 activation of pDCs and Treg cell induction
can also mediate protection in extra-intestinal inflamma-
tory diseases such as experimental autoimmune
encephalomyelitis, a multiple sclerosis animal model.33,34
Additional work characterizing PSA-induced Treg cell
activation via MHCII-mediated antigen presentation sug-
gests that the interaction depends on the zwitterionic
(carries positive and negative charges) properties of PSA
and induces a specific clonal expansion of Treg cells.42
Lactobacillus plantarum teichoic acid D-alanylation (com-
ponent of Gram-positive bacterial envelope) also signals
through TLR2 and promotes a pro-inflammatory cytokine
response in DCs, which modulates effector and regulatory
T-cell populations45 (Fig. 2).
Bacteria flagellin is recognized by TLR5 expressed on
various cells including intestinal epithelial cells (IECs)
and DCs. The IEC-derived TLR5 signalling appears to
influence microbiota composition and host response
because TLR5DIEC mice have an altered microbiota com-
pared with co-housed sibling wild-type controls, develop
low-grade inflammation and metabolic syndrome, and
have delayed clearance of adherent invasive Escherichia
coli (AIEC).46 How TLR5 activation controls composition
of the microbiota is unclear but could involve immune
cell recruitment to clear pathogens in close proximity to
the epithelium, stimulation of epithelial antimicrobial
peptide production, or induction of flagellin-specific
Table 1. Examples of specific bacteria that modulate the host immune system
Bacteria Immunomodulatory effect Mechanism References
AIEC Induce inflammatory cytokines in vitro Activation of NLRP3 in macrophages,
inducing IL-1b production
(55)
Bacteroides
fragilis
Influence Treg cell development and homeostasis
Influence iNKT cell homeostasis
Bacterial PSA/OMVs containing
PSA interactions with TLR2 on pDCs
(32–34, 36,
42, 56)
Bacterial sphingolipids modulate iNKT
development and activation
(37,38)
Bacteroides
thetaiotaomicron
Promote intracellular calcium signaling,
nutritional benefits in IECs Promote colitis
in CD4-dnTgfb2;IL10rb/ mice
Bacterial OMVs containing inositol phosphatase (40)
Bacterial OMVs containing sulphatase,
degrade mucin glycans
(35)
Clostridium
scindens
Inhibit Clostridium difficile infection Bacterial secondary bile acid synthesis (64)
ETBF Induce Th17 cells, enhance tumorigenesis
in mouse models of CRC
Bacterial toxin-dependent OMVs induce host IECs
to secrete sphingolipids
(56)
Lactobacillus
plantarum
Alter distribution of pro- and anti-inflammatory
T-cell and DC populations
Bacterial teichoic acid D-alanylation signalling
through TLR2
(45)
Proteus mirabilis Induce intestinal inflammation in DSS model Dependent on bacterial haemolysin; activation of NLRP3
inflammasome, inducing IL-1b production
(30,44)
SFB Induce IgA and Th17 Stimulation of germinal centres and induction
of IgA-secreting cells; MHCII presentation by DCs and ILCs
(14–16)
Staphylococcus
epidermidis
Induce CD8+ T cells to the epidermis,
enhance barrier function
Interactions with CD103+ DCs (27)
Sutterella
species
Alter faecal IgA levels Degradation of the secretory component of IgA (10)
AIEC, adherent invasive Escherichia coli; DCs, dendritic cells; ETBF, enterotoxigenic Bacteroides fragilis; IECs, intestinal epithelial cells; IgA,
immunoglobulin A; ILCs, innate lymphoid cells; iNKT, invariant natural killer T cell; OMVs, outer membrane vesicles; pDCs, plasmacytoid den-
dritic cells; PSA, polysaccharide A; SFB, segmented filamentous bacteria; Th17, T helper 17.
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IgA.46 The microbiota also impacts vaccine immunity
through TLR5 signalling in B cells and macrophages,
which is critical for mounting an antibody response to
trivalent inactivated influenza vaccine and the inactivated
polio vaccine.47
Most of the downstream signalling from TLRs occurs
through either myeloid differentiation primary response
protein 88 (MyD88) or Toll–interleukin receptor domain-
containing adaptor protein inducing interferon-b (TRIF)
adaptor proteins, resulting in activation of nuclear factor-
jB or interferon regulatory factors, respectively.48 Lumi-
nal bacteria promote mucus secretion and movement of
monocytes closer to epithelial stem cells through an
epithelial MyD88-signalling pathway. Increased proximity
of monocytes to epithelial stem cells results in increased
crypt cell proliferation and intestinal stem cell numbers,49
which could be beneficial during intestinal injury
response. Studies comparing GF mice to mice colonized
with three strains of bacteria (E. coli K-12, Staphylococcus
xylosus and Enterococcus faecalis) reveal that GF mice have
delayed microbial clearance, reduced inflammatory
responses to intravenous E. coli K12 infection and a
decreased myeloid cell pool size.50 Heat-stable microbial
antigens in the serum are able to restore bone marrow
myeloid cell numbers through MyD88/Toll-interleukin 1
receptor domain-containing adaptor molecule (TICAM)-
dependent TLR signalling.50 MyD88-dependent TLR sig-
nalling also plays a role in microbiota-mediated tolerance
to a non-invasive strain of Salmonella enterica serovar
Typhimurium by preventing CX3CR1
hi mononuclear
phagocyte-mediated transport of luminal bacteria to the
mesenteric lymph nodes.51 Furthermore, tumour necrosis
factor receptor associated factor 6 (TRAF6), a component
of TLR signal transduction, has MyD88-independent
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Figure 2. Bacterial components that affect innate and adaptive immunity in the intestine. Bacterial MAMPS signal through host PRRs. PSA (A)
from Bacteroides fragilis interacts with TLR2 on plasmacytoid pDCs to induce IL-10 production from CD4+ T cells and Treg clonal expansion.
Lactobacillus plantarum D-alanylated teichoic acid (D) also signals through TLR2 on DCs to modulate effector and regulatory T-cell populations.
Flagellin activation of TLR5 on epithelial cells alters microbiota composition. Luminal bacteria promote mucus secretion and movement of
monocytes closer to epithelial stem cells through a MyD88-dependent signalling pathway. Sphingolipid metabolites from B. fragilis promote iNKT
activation in adults. SCFA metabolites from bacteria impact immunity through multiple mechanisms: activation of GPRs, inhibition of HDACs,
and regulation of autophagy. Butyrate exerts anti-inflammatory effects on macrophages through HDAC inhibition and promotes barrier function
in IECs through stabilization of HIF. Lactobacilli produce an AhR ligand, indole-3-aldehyde, which induces IL-22, promoting AMP expression
and mucosal homeostasis. AhR signalling on ILC3s also inhibits Th17 cell expansion. AhR, aryl hydrocarbon receptor; AMPs, antimicrobial pep-
tides; GPRs, G protein-coupled receptors; HIF, hypoxia-inducible factor; I, indole-3-aldehyde, an AhR ligand; IECs, intestinal epithelial cells,
ILC3, group 3 innate lymphoid cell; MAMPS, microbe-associated molecular patterns; MyD88, myeloid differentiation primary response protein
88; PRRs, pattern recognition receptors; pDCs, plasmacytoid dendritic cells; PSA, polysaccharide A from Bacteroides fragilis; SCFAs, short-chain
fatty acids; TLRs, Toll-like receptors.
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effects on immune and microbiota homeostasis. Mice
with TRAF6-deficient DCs develop Th2-driven small
intestine inflammation and have decreased Treg cells,
both of which are microbiota-dependent.52
Nod-like receptors (NLRs) are a class of cytosolic PRRs
that act as intracellular sensors.3 Nod2 recognizes bacte-
rial peptidoglycan through muramyl dipeptide. Studies
using Nod2/ mice reveal reduced intraepithelial lym-
phocytes (IELS) and administering muramyl dipeptide to
antibiotic-treated mice restored IEL numbers through up-
regulation of IL-15, suggesting that Nod2-mediated recog-
nition of the microbiota affects IEL homeostasis.53 Nod2
has also been implicated in preventing goblet cell dys-
function and restricting expansion of Bacteroides vulgatus
in the small intestine, which prevents piroxicam-induced
intestinal inflammation in mice.54 The NLRs also have
extra-intestinal effects, as NLR ligands have been impli-
cated in innate immunity in the lung, which is important
for Klebsiella pneumoniae clearance.43
Inflammation or injury can cause members of the
microbiota to become pathogenic and stimulate the
immune system to induce inflammation. In the context
of a dextran sulphate sodium (DSS) mouse model, Pro-
teus mirabilis can induce IL-1b production via NLR
family, pyrin domain containing 3 (NLRP3) inflamma-
some activation in recruited inflammatory monocytes,
promoting intestinal inflammation.44 After comparing
different strains, the authors determined that Proteus mir-
abilis HpmA haemolysin induces K+ efflux, which is
required for NLRP3-induced inflammasome
activation.30,44 In vitro studies show that AIEC isolated
from patients with IBD are also able to induce IL-1b
through NLRP3 activation in macrophages.55
Outer membrane vesicles
Outer membrane vesicles (OMVs) are produced by
Gram-negative bacteria and contain various bacterial
components, many of which activate PRRs.39 The OMVs
can promote immune homeostasis or enhance bacterial
pathogenesis; effects that probably depend on the type of
bacteria, OMV content and host environment.39 For
example, Bacteroides thetaiotaomicron OMVs containing
homologues of mammalian inositol phosphatase interact
with IECs in vitro to promote intracellular calcium sig-
nalling.40 This signalling confers nutritional benefits and
potentially anti-carcinogenic properties, as dietary inositol
hexaphosphate administration reduces tumorigenesis in
carcinogen (1,2-dimethylhydrazine or azoxymethane) -
induced cancers in rats and mice.40 On the other hand,
spontaneous colitis-prone CD4-dnTgfb2;IL10rb/ mice
exposed to B. thetaiotaomicron develop inflammation due
to OMVs containing sulphatase activity, which degrades
mucin glycans and allows B. thetaiotaomicron to interact
with host macrophages.35 Bacterodies fragilis PSA is also
released in OMVs, which can be detected by TLR2.36,56
Some bacteria produce OMVs that have adverse effects
on host immunity. For example, enterotoxigenic B. frag-
ilis secrete B. fragilis toxin-dependent particles that can
induce host IECs to secrete sphingolipids (specifically,
sphingosine-1-phosphate) in exosome-like particles,
which induce Th17 cells and enhance tumorigenesis in
multiple colon cancer mouse models.56
Metabolites
Besides structural components, bacteria also generate a
wide spectrum of metabolites that have the capacity to
engage and trigger numerous host responses (Fig. 2).
Multiple intestinal Bacteroides species are able to synthe-
size sphingolipids, which are structurally similar to host
lipid agonists of iNKT cells. Bacteroides fragilis sphin-
golipids have been shown to modulate cellular homeosta-
sis by both promoting iNKT cell activation37 and
inhibiting activation and expansion of iNKT cells during
mouse neonatal development, which protects against oxa-
zolone-induced colitis in adulthood.38
Short-chain fatty acids (SCFAs) are bacterial metabolites
generated as by-products of dietary fibre fermentation.
Butyrate, propionate and acetate are the most common
intestinal SCFAs and are normally present in the millimo-
lar range in the gut. The mechanisms by which SCFAs
impact immunity include activation of G protein-coupled
receptors (GPRs), inhibition of histone deacetylases, and
regulation of autophagy.57 Levels of SCFAs depend on two
interdependent factors: dietary fibre and microbiota com-
position. The SCFAs may modulate protection against
chemically induced DSS colitis through GPR43 and
GPR109A receptor interactions, which are dependent on
the NLRP3 inflammasome in non-haematopoietic cells.58
Butyrate exerts anti-inflammatory effects on bone mar-
row-derived and colonic macrophages via histone deacety-
lase inhibition. However, gavaging mice with butyrate does
not impact the outcome of DSS colitis, suggesting that
butyrate promotes bacterial tolerance rather than tissue
repair.59 Additionally, butyrate has been shown to increase
barrier function by stimulating epithelial metabolism in
the colon to promote oxygen depletion, stabilizing hypox-
ia-inducible factor and inducing hypoxia-inducible factor-
dependent target genes that promote barrier function.60
SCFAs from the microbiota can also have systemic effects.
In a mouse model of allergic inflammation in the lung,
high levels of propionate are protective, probably through
GPR41 signalling, which results in DCs with high phago-
cytic capability and an impaired capacity to induce Th2
differentiation.41
In addition, microbial metabolites can influence host
immune responses through an indirect route. For exam-
ple, SCFAs augment 5-hydroxytryptamine (serotonin)
production from intestinal enterochromaffin cells through
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up-regulation of the rate-limiting biosynthetic enzyme
tryptophan hydroxylase.61 The wide impact of serotonin
on host biological response including immunity62 suggests
that microbes could shape immune responses through
complex mechanisms. SCFAs also directly impact innate
immune cells in the brain and central nervous system.
Germ-free mice have defects in microglial (tissue macro-
phages of the brain) maturation, differentiation and func-
tion with a diminished response to lipopolysaccharides
and viral challenges, while administering a mixture of
propionate, butyrate and acetate to the drinking water
restores microglial maturation.63 Indigenous bacteria
metabolites may have key roles in inhibiting colonization
of specific pathogens. For instance, Clostridium scindens
inhibition of Clostridium difficile is associated with sec-
ondary bile acid synthesis.64
Tryptophan catabolites from the microbiota expand lac-
tobacilli that produce an aryl hydrocarbon receptor (AhR)
ligand, indole-3-aldehyde. Activation of AhR results in IL-
22 transcription that promotes antimicrobial peptide
expression and mucosal homeostasis, providing coloniza-
tion resistance against gastrointestinal or vaginal Candida
albicans infection and DSS colitis models.65 Group 3 ILCs
also rely on AhR signalling to inhibit Th17 cell expansion
and regulate SFB levels, which could play a role in IBD
because ~ 40% of mice that lack AhR signalling abilities in
ILCs develop spontaneous colitis between 12 and 20 weeks
of age and have exacerbated inflammation in a CD45RBhi
T-cell transfer model of colitis.66 In summary, bacterial
components and metabolites affect both innate and adap-
tive immunity in the intestine (Fig. 2).
Viral, archaeal and eukaryotic microbiota
members that influence immunity
Part of how the microbiota impacts host immunity is by
limiting pathogen colonization through niche occupation
and resource use. These indirect protective effects may
extend to the viral members of the microbiota, of which
there are an estimated 109 viruses per gram of faeces.
Some of these viruses target mammalian cells but bacte-
riophages, which exclusively infect bacteria, make up the
majority of the virus community.67 Bacteriophages dis-
playing immunoglobulin-like domains on phage capsid
proteins adhere to host intestinal mucus and are able to
reduce microbial colonization in the mucosal niche by
infecting and lysing bacteria.68 Recently, metagenomic
sequencing of the human faecal virome from healthy peo-
ple and patients with IBD revealed an expansion of Cau-
dovirales bacteriophages associated with IBD.69 Hence,
microbiota-associated bacteriophages may impact the
pathogenesis of IBD by targeting microbial members with
protective or deleterious function.
When it comes to immune system development and
function, viral members of the microbiota may be able to
confer some of the same immune benefits as bacteria.
Murine norovirus infection of GF or antibiotic-treated
mice restores intestinal morphology and lymphocyte
function, and suppresses group 2 ILC (ILC2) expansion;
additionally RNA-sequencing revealed transcriptional
changes in the intestine associated with immune develop-
ment and type I interferon signalling.70 Whether viruses
contribute to human immune system development and
homeostasis remains to be determined.
Archaeal members of the microbiota can also activate
host immune cells. Specifically Methanosphaera and
Methanorevibacter have differential capacities to induce
pro-inflammatory cytokine release from human DCs.
Activation requires phagocytosis of the archaea, but
whether induction involves PRRs that recognize compo-
nents of the archaeal cell envelope is still unknown.71
Studies examining the immunomodulatory effects of
the fungal microbiota have mostly focused on one of the
most abundant members, Candida albicans, which can
cause severe infections in immunocompromised people.2
The host uses TLRs as well as C-type lectins, a class of
PRRs, to recognize fungal cell wall components such as
mannans, b-glucans and chitin.2,72 The cell wall compo-
nents of Candida albicans are immunomodulators, with
cell wall glycosylation playing a key role in inducing pro-
inflammatory cytokine expression, proliferation and
apoptosis in epithelial cells.72 Chitin induces secretion of
the anti-inflammatory cytokine IL-10, which is dependent
on NOD2, TLR9, and mannose receptors. Anti-inflamma-
tory cytokines induced by chitin may play a role in
resolving immune homeostasis after pathogen clearance
and eosinophilia, which is a feature of asthma.73
Helminths are parasitic worms that modulate host
immunity by inducing a strong Th2 immune response,
Treg cells and regulatory cytokines such as IL-10 and
transforming growth factor-b.74 Epidemiological evidence
and experimental studies suggest that the helminth-
induced immune response may be therapeutic for treating
allergies and autoimmune diseases.75 Recent research
focused on identifying the helminth immunomodulatory
products has revealed that administering excretory/secre-
tory products from Trichinella spiralis adult worms pro-
tects mice from DSS-induced colitis through up-
regulation of Treg cells and reduction of pro-inflamma-
tory cytokines.74 The Acanthocheilonema viteae product
(AvCystatin) modulates MAPK, p38 and ERK pathways
in macrophages to induce IL-10 secretion. Administration
of AvCystatin-treated macrophages to mice with OVA-
induced airway inflammation or DSS-induced colitis
ameliorates disease by suppressing inflammation.76 How-
ever, in the context of viral infection, the helminth
immune response may be detrimental. Trichinella spiralis-
infected mice induce alternative activation of macro-
phages, which up-regulates genes that impair the T-cell
response to murine norovirus.77
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Bacterial adaptations to host immune
mechanisms
Previous sections have examined how microbes direct
immune development and function. However, the
immune system also impacts microbes, which includes
influencing microbiota composition as well as virulence
capacities. Mechanisms by which specific microbes have
adapted to coexist with the host immune system have
begun to emerge (Table 2). For example, B. thetaiotaomi-
cron uses lipid A dephosphorylation to resist host antimi-
crobial peptides that target the lipopolysaccharide portion
of the bacterial outer membrane.78
Part of the immune response to infection can promote
indigenous microbiota colonization through release of
nutrients. TLR agonists induce DC IL-23 production in a
MyD88-dependent manner, which stimulates ILCs to pro-
duce IL-22, resulting in rapid fucosylation of small intes-
tine epithelial cells.79 Work by Goto et al. demonstrated
that bacteria such as SFB, stimulate IL-22 production by
ILC3s, which mediates epithelial fucosylation in the ileum
and protects the host from Salmonella typhimurium infec-
tion.80 Resident bacteria, such as Bacteroides acidifaciens,
have the capacity to cleave fucose, which can subse-
quently be used by other members of the microbiota; a
process that may promote tolerance to intestinal patho-
gens.79 Host IL-22RA1 signalling promotes intestinal
fucosylation in colonic organoids and the mouse caecum,
restoring anaerobic bacterial diversity in the colon to pro-
tect against opportunistic pathogens such as Enterococcus
faecalis and Citrobacter rodentium.81 Hence, fucosylation
seems to be a host response to specific members of the
microbiota or infectious challenge, which bolsters the
microbiota and protects the host from multiple enteric
pathogens. Reinforcing the importance of IL-22 produc-
tion in maintaining colonization resistance against enteric
pathogens, ID2 (a transcriptional regulator of ILCs) pro-
motes colonization resistance against Citrobacter roden-
tium by mediating IL-22 production by ILC3s through an
AhR and IL-23 receptor pathway.82
Some pathogenic bacteria have evolved virulence factors
that allow them to better cope with host immune defence
mechanisms compared with indigenous bacteria. Inter-
leukin-22 is part of the immune response to infection and
leads to induction of lipocalin-2 and calprotectin, which
sequester iron, zinc and manganese ions. Salmonella enterica
serovar Typhimurium overcomes host iron sequestration
with the siderophore salmochelin and zinc sequestration
through a zinc transporter, giving Salmonella a colonization
advantage over resident Enterobacteriaceae that lack addi-
tional siderophores.83 Fusobacterium nucleatum, which has
previously been linked to colon cancer,84 is able to bind to
an inhibitory receptor (TIGIT) on NK and T cells, leading
to inhibition of NK cell-mediated cytotoxicity/T-cell activi-
ties.85 Additionally, the authors demonstrate F. nucleatum
OMVs bind TIGIT suggesting a pro-carcinogenic role for
F. nucleatum OMVs by inhibiting host immune function.85
This bilateral communication between microbes and the
host clearly highlights the intricate and complex nature of
microbe–host interactions.
Conclusions/Perspective
The impact of the microbiota on myriad components of
innate and adaptive immunity has been well established,
especially in the intestine. Recent studies have moved on
to characterizing how members of the microbiota and the
host immune system communicate with one another. It is
likely that the dialogue between microbes and host is a
dynamic phenomenon, taking place from birth and evolv-
ing over time, even though the phylogenic microbial
composition is quite stable for the majority of life. There-
fore, microbial bioactivities rather than composition may
account for most of the host response, including immu-
nity. Clearly, more information is needed on the specific
nature of this dialogue and how communication break-
downs result in disrupted host immune homeostasis. It
will be important to continue detailing the relationship
between microbially derived metabolites and host
immune homeostasis. These studies should include
Table 2. Examples of bacterial adaptations to host immune mechanisms
Bacteria Host Immune component Bacterial response References
Bacteroides thetaiotaomicron Antimicrobial peptides Resistance through outer membrane
lipid A dephosphorylation
(78)
Indigenous bacteria Fucosylation of IECs triggered
by SFB or enteric infection
Metabolic capacity to cleave fucose, use fucose (79–82)
Salmonella enterica
serovar Typhimurium
Induction of lipocalin-2 and calprotectin Additional siderophores and zinc
transporters to overcome host
metal ion sequestration
(83)
Fusobacterium nucleatum NK cytotoxicity and T cell effector functions Binds host inhibitory receptor
(TIGIT) on NK and T cells
(85)
IECs, intestinal epithelial cells; NK, natural killer; SFB, segmented filamentous bacteria; TIGIT, an inhibitory receptor on NK and T cells.
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transcriptomic and metabolomic approaches to better
understand the impact of microbial activities on the host
immune response. The continuous characterization of
microbial communities at the genomic and proteomic
levels, in conjunction with specific culture methods, will
contribute to understanding how specific microbes shape
the immune response. Ahern et al. offer a possible
approach for identifying members of the human micro-
biota that impact the immune system using gnotobiotic
mice.86 The persistent mapping and annotation of micro-
bial genes in conjunction with the establishment of tools
to genetically modify these genes will enable molecular
dissection of the contributions of bacteria to host immu-
nity. Additionally, it is likely that more interactions occur
between members of the microbiota (viruses, prokaryotes
and eukaryotes) that influence host immune health than
are currently known. Continued research focused on the
signalling that occurs between microbiota components
and the immune system may lead to the development of
new or improved strategies to restore or reset altered
communication networks between the host and microbes.
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